Modification of metabolic syndrome parameters following the administration of polyglucosamine L112: results of a subgroup analysis of subjects enrolled in a double blind randomised placebo controlled clinical investigation

Abstract Background Up to now, scientific literature has not reported studies evaluating the efficacy of polyglucosamine L112 on body weight, insulin resistance, and cholesterol levels in patients with metabolic syndrome, despite its known antioxidant properties and potential to reduce these paramet...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Mariangela Rondanelli, Simone Perna, Matteo Della Porta, Federico Lombardoni, Zaira Patelli, Mara Nichetti, Clara Gasparri, Elvira Pistolesi, Benvenuto Cestaro, Roberta Cazzola
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BMC 2025-09-01
סדרה:	BMC Nutrition
נושאים:	Polyglucosamine L112 Metabolic syndrome Insulin resistance Visceral adipose tissue Fat mass Fat-soluble vitamins
גישה מקוונת:	https://doi.org/10.1186/s40795-025-01153-8
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!